HomeBXPHF • OTCMKTS
add
Botanix Pharmaceuticals Ltd
Nakaraang pagsara
$0.23
Sakop ng taon
$0.062 - $0.50
Market cap
760.58M AUD
Average na Volume
6.55K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 188.80K | -0.09% |
Gastos sa pagpapatakbo | 15.57M | 532.16% |
Net na kita | -15.44M | -464.98% |
Net profit margin | -8.18K | -465.47% |
Kita sa bawat share | — | — |
EBITDA | -15.43M | -459.15% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 48.44M | 164.49% |
Kabuuang asset | 99.45M | 108.57% |
Kabuuang sagutin | 6.96M | 203.76% |
Kabuuang equity | 92.49M | — |
Natitirang share | 1.82B | — |
Presyo para makapag-book | 4.60 | — |
Return on assets | -40.19% | — |
Return on capital | -42.81% | — |
Cash Flow
Net change in cash
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -15.44M | -464.98% |
Cash mula sa mga operasyon | -15.28M | -712.75% |
Cash mula sa pag-invest | -426.99K | 94.22% |
Cash mula sa financing | 200.20K | -98.50% |
Net change in cash | -15.44M | -482.88% |
Malayang cash flow | -4.57M | 45.34% |
Tungkol
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Itinatag
1984
Website
Mga Empleyado
11
